ReviewTherapeutic advances in gastroenterology2016

Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.

Xiaojun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.